Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
2.
Intern Med J ; 54(6): 925-931, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38263859

ABSTRACT

BACKGROUND: There are few reports on drug use in patients while hospitalised and none regarding management or clinical outcomes. AIMS: To describe cases of drug use by inpatients requiring an urgent clinical response. METHODS: We retrospectively reviewed cases at a teaching hospital in Sydney, Australia, from February 2019 to March 2021. RESULTS: Thirty cases were identified, with no deaths. Two patient groups were identified: (i) substance use disorders, using illicit drugs and (ii) self-harm history, using prescribed or over-the-counter drugs. Management involved cardiac monitoring (40%), intensive care (30%), charcoal (20%), antidotes (20%) and intubation (13%). Discharge was planned in 22 of 30 patients, against medical advice in four and directed by medical staff in four. CONCLUSIONS: Inpatient drug use requiring an urgent clinical response was infrequently recognised but presents a risk of harm to patients and staff and increases service utilisation and costs. Both harm reduction and systematic approaches guided by institutional policy are recommended. Using these events as reachable moments to address driving factors may modify patients' risk from future events.


Subject(s)
Hospitalization , Substance-Related Disorders , Humans , Male , Female , Retrospective Studies , Substance-Related Disorders/therapy , Substance-Related Disorders/epidemiology , Middle Aged , Adult , Aged , Australia/epidemiology , Young Adult
4.
ANZ J Surg ; 92(10): 2425-2432, 2022 10.
Article in English | MEDLINE | ID: mdl-35920692

ABSTRACT

Cystic fibrosis (CF) is a complex multiorgan disease, which often affects the gastrointestinal tract. With improved CF specific therapies and multidisciplinary management, patients with CF are now living longer with a median life expectancy of around 50 years. This increased life expectancy has resulted in corresponding increase in presentations of the CF patient with comorbid surgical conditions that were never important considerations. Investigations and management of these conditions, such as distal intestinal obstruction syndrome and colorectal cancer warrant good clinical understanding of the unique challenges that CF patients present including chronic immunosuppression, impaired respiratory function and their multi-organ dysfunction. The purpose of this review is to provide general surgeons with a contemporary update on the CF related surgical issues as they are likely to become increasingly involved in the care of these complex patients and form an integral part of the multidisciplinary team.


Subject(s)
Cystic Fibrosis , Intestinal Obstruction , Surgeons , Cystic Fibrosis/complications , Cystic Fibrosis/surgery , Humans , Intestinal Obstruction/etiology , Intestinal Obstruction/surgery
SELECTION OF CITATIONS
SEARCH DETAIL